Jesús F. San Miguel — Impact Story

Jesús F. San Miguel 2025 EHA–EMN Evidence-Based Guidelines for diagnosis, treatment and follow-up of patients with multiple myeloma 2025 • Meletios Α. Dimopoulos, Evangelos Terpos, Mario Boccadoro, Philippe Moreau, María‐Victoria Mateos, Sonja Zweegman, Gordon Cook, Monika Engelhardt,... 2025 Co-Occurrence of Cytogenetic Abnormalities and High-Risk Disease in Newly Diagnosed and Relapsed/Refractory Multiple Myeloma 2025 • Martin Kaiser, Pieter Sonneveld, David A. Cairns, Marc S. Raab, Jesús F. San Miguel, Rick Zhang, Jorge Acosta‐Reyes, Alessandra Larocca, Rakesh Pop... 2025 European Myeloma Network Group review and consensus statement on primary plasma cell leukemia 2025 • Pellegrino Musto, Monika Engelhardt, Niels W.C.J. van de Donk, Francesca Gay, Evangelos Terpos, H. Einsele, Carlos Fernández de Larrea, N. Sgherza,... 2025 Ultrasensitive detection of circulating multiple myeloma cells by next-generation flow after immunomagnetic enrichment 2025 • Marta Lasa, Carmen González, Laura Notarfranchi, Anastasiia Zherniakova, Diego Alignani, Leire Burgos, Marı́a José Calasanz, Paula Rodríguez‐Otero,... 2025 Safety and activity of talquetamab in patients with relapsed or refractory multiple myeloma (MonumenTAL-1): a multicentre, open-label, phase 1–2 study 2025 • Ajai Chari, Cyrille Touzeau, Carolina Schinke, Monique C. Minnema, Jesús G. Berdeja, Albert Oriol, Niels W.C.J. van de Donk, Paula Rodríguez‐Otero,... Open Author Page

Exploring foci of 2025-03-13 Safety and activity of talquetamab in patients with relapsed or refractory multiple myeloma (MonumenTAL-1): a multicentre, open-label, phase 1–2 study 2025-03-13 • Ajai Chari, Cyrille Touzeau, Carolina Schinke, Monique C. Minnema, Jesús G. Berdeja, Albert Oriol, Niels W.C.J. van de Donk, Paula Rodríguez‐Otero,... Janssen. Open Article Page

Human Sexual Activity Safety Valve Routine Activity Theory The Safety Dance Mobile Phones And Driving Safety Safety (Gridiron Football Score) Committee Of Public Safety Activity-Based Costing Safety Not Guaranteed Open Article Page

Exploring foci of 2025-07-07 EHA–EMN Evidence-Based Guidelines for diagnosis, treatment and follow-up of patients with multiple myeloma 2025-07-07 • Meletios Α. Dimopoulos, Evangelos Terpos, Mario Boccadoro, Philippe Moreau, María‐Victoria Mateos, Sonja Zweegman, Gordon Cook, Monika Engelhardt,... Open Article Page

Medicine Multiple Myeloma Oncology Internal Medicine Law Open Article Page

Exploring foci of 2025-02-18 Co-Occurrence of Cytogenetic Abnormalities and High-Risk Disease in Newly Diagnosed and Relapsed/Refractory Multiple Myeloma 2025-02-18 • Martin Kaiser, Pieter Sonneveld, David A. Cairns, Marc S. Raab, Jesús F. San Miguel, Rick Zhang, Jorge Acosta‐Reyes, Alessandra Larocca, Rakesh Pop... PURPOSE Survival for patients with multiple myeloma (MM) has improved but outcomes remain heterogeneous. Consistent diagnostic identification of high-risk disease is desirable to address unmet patient need. The aim was to investigate the consistency of association of co-occurrence of high-risk cytogenetic abnormalities (HRCAs) with prognosis in patients with newly diagnosed MM (NDMM) and relapsed/refractory MM (RRMM), and across a range of treatment modalities. METHODS A systematic review of randomized controlled … Open Article Page

Co-Occurrence Matrix Open Article Page

Exploring foci of 2025-02-07 European Myeloma Network Group review and consensus statement on primary plasma cell leukemia 2025-02-07 • Pellegrino Musto, Monika Engelhardt, Niels W.C.J. van de Donk, Francesca Gay, Evangelos Terpos, H. Einsele, Carlos Fernández de Larrea, N. Sgherza,... Open Article Page

Active Club Network Global Cycling Network Passports Of The European Union Uefa European Championship Feedforward Neural Network Proto-Indo-European Language European Mantis European Athletics Team Championships European Union Competition Law Open Article Page

Exploring foci of 2025-05-22 Ultrasensitive detection of circulating multiple myeloma cells by next-generation flow after immunomagnetic enrichment 2025-05-22 • Marta Lasa, Carmen González, Laura Notarfranchi, Anastasiia Zherniakova, Diego Alignani, Leire Burgos, Marı́a José Calasanz, Paula Rodríguez‐Otero,... Abstract The continuous improvement in progression-free survival (PFS) of patients with multiple myeloma (MM) raises interest in evaluating peripheral residual disease (PRD) toward more frequent readouts of tumor kinetics while preserving quality of life. We present BloodFlow, a new method combining immunomagnetic enrichment of CD138+ circulating plasma cells in peripheral blood (PB) with next-generation flow (NGF), for the detection of PRD below the 2 × 10–6 NGF threshold. BloodFlow detected PRD in 55 of 644 PB s… Open Article Page

Multiple Myeloma Flow Cytometry Bone Marrow Medicine Internal Medicine Urology Histopathology Oncology Immunology Open Article Page